Interestingly, we observed that dinaciclib synergizes with BH3 mimetics binding to BCL‐2 or BCL‐XL and increases apoptosis rates in some MM cell lines and plasma cells from MM patients, ex vivo. The gene discussed is BCL2L1; the disease is Miyoshi myopathy.